Publications by authors named "V Curci"

This study aimed to research Toxoplasma gondii DNA in 102 samples of raw bovine milk from expansion tanks, in small properties located in different cities of the Midwest region of São Paulo, Brazil. For this, polymerase chain reaction (PCR) was performed with the primers TOX4/TOX5 for cPCR (conventional PCR), TgNP1/TgNP2 gene for nested PCR and the Tg18s58F/Tg18s348R for nested PCR. It was possible to detect T.

View Article and Find Full Text PDF

Background And Objectives: Feline leishmaniasis (FeL) is caused by several species of parasites of the genus . The disease can occur with the presence or absence of clinical signs, similar to those observed in other common infectious diseases. In endemic regions for FeL, the infection has been associated with dermatological lesions.

View Article and Find Full Text PDF

Stroke recovery trajectories vary substantially. The need for tracking and prognostic biomarkers in stroke is utmost for prognostic and rehabilitative goals: electroencephalography (EEG) advanced signal analysis may provide useful tools toward this aim. EEG microstates quantify changes in configuration of neuronal generators of short-lasting periods of coordinated synchronized communication within large-scale brain networks: this feature is expected to be impaired in stroke.

View Article and Find Full Text PDF

Objective: To perform an early economic evaluation of a system based on photodynamic advanced adjuvant therapy with photosensitizer RLP068/CI to facilitate the healing process of foot/leg skin lesions/ulcers with an excellent safety profile.

Design: An early short-term (10 weeks) cost-effectiveness and a budget impact analysis (over 5 years) comparing photodynamic therapy with photosensitizer RLP068/CI based (PDT-RLP068) system added to Standard of Care (SoC) vs SoC alone.

Setting: The Italian National Healthcare System perspective considering both the outpatient and the day-hospital regimen.

View Article and Find Full Text PDF
Article Synopsis
  • * Advances in photomedicine have led to the development of treatments like RLP068, a light-activated zinc compound that targets infections without harming surrounding tissues, using red light to produce reactive oxygen species that kill bacteria and fungi.
  • * A study involving 22 patients treated with photoactivated RLP068 showed promising results, including a notable reduction in microbial load and a healing rate of 41%, suggesting that RLP068 could be both effective and cost-efficient for treating DFUs.
View Article and Find Full Text PDF